ANI Pharmaceuticals Inc’s recent filing unveils that its SVP, CHIEF HR OFFICER Davis Krista unloaded Company’s shares for reported $0.12 million on Mar 19 ’25. In the deal valued at $65.00 per share,1,866 shares were sold. As a result of this transaction, Davis Krista now holds 64,659 shares worth roughly $4.29 million.
Then, Cook Meredith sold 400 shares, generating $25,332 in total proceeds. Upon selling the shares at $63.33, the SR. VP, GENERAL COUNSEL & SEC. now owns 80,545 shares.
Before that, Davis Krista sold 1,000 shares. ANI Pharmaceuticals Inc shares valued at $60,860 were divested by the SVP, CHIEF HR OFFICER at a price of $60.86 per share. As a result of the transaction, Davis Krista now holds 66,525 shares, worth roughly $4.41 million.
Jefferies initiated its ANI Pharmaceuticals Inc [ANIP] rating to a Buy in a research note published on March 14, 2025; the price target was $80. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. Leerink Partners began covering ANIP with “an Outperform” recommendation on December 11, 2024. Piper Sandler started covering the stock on October 11, 2024. It rated ANIP as “an Overweight”.
Price Performance Review of ANIP
On Tuesday, ANI Pharmaceuticals Inc [NASDAQ:ANIP] saw its stock jump 0.53% to $66.33. Over the last five days, the stock has gained 3.29%. ANI Pharmaceuticals Inc shares have risen nearly 19.99% since the year began. Nevertheless, the stocks have fallen -4.31% over the past one year. While a 52-week high of $70.81 was reached on 03/25/25, a 52-week low of $52.50 was recorded on 01/13/25. SMA at 50 days reached $59.69, while 200 days put it at $59.54.
Levels Of Support And Resistance For ANIP Stock
The 24-hour chart illustrates a support level at 64.67, which if violated will result in even more drops to 63.01. On the upside, there is a resistance level at 68.06. A further resistance level may holdings at 69.80. The Relative Strength Index (RSI) on the 14-day chart is 65.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.42, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 17.33%. Stochastics %K at 88.84% indicates the stock is a selling.
How much short interest is there in ANI Pharmaceuticals Inc?
A steep rise in short interest was recorded in ANI Pharmaceuticals Inc stocks on 2025-03-14, growing by 21693.0 shares to a total of 2.58 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 2.56 million shares. There was a rise of 0.84%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 15, 2024 when CapitalOne began covering the stock and recommended ‘”an Overweight”‘ rating along with a $80 price target.
